Shares of RESMED/IDR UNRESTR (ASX:RMD) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.00 and traded as low as $17.31. RESMED/IDR UNRESTR shares last traded at $17.41, with a volume of 1,418,078 shares.

The company has a current ratio of 2.38, a quick ratio of 1.44 and a debt-to-equity ratio of 66.08. The stock has a market cap of $24.96 billion and a PE ratio of 56.36. The business has a fifty day simple moving average of A$17.19.


ResMed Inc develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.

See Also: Understanding the two types of arbitrage

Receive News & Ratings for RESMED/IDR UNRESTR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RESMED/IDR UNRESTR and related companies with's FREE daily email newsletter.